**What drug made 2023 a revolutionary year for weight loss? ** **✔️ Wegovy**, initially prescribed f
 secreted from the L-cells of the small intestine and colon and specialized cells in the brainstem within a few minutes of eating.
✔️ In a two-year trial, Wegovy participants shed 15% body weight, dwarfing the control group's 3%. Trials also hinted at its potential benefits like reducing heart attack and stroke risks and aiding addiction treatment.
✔️ However, Wegovy's side effects, like nausea and a potential risk of thyroid cancers, caution against unbridled optimism.
ℹ️ Global obesity affects 650 million adults, surpassing undernourished populations at 735 million.
Subscribe- t.me/askmenow](https://dfs98oe0smqfo.cloudfront.net/askmenow/2024-01-17/3665.jpg)
**What drug made 2023 a revolutionary year for weight loss? ** **✔️ Wegovy**, initially prescribed for diabetes, **emerged as a revolutionary weight-loss drug**. Never before has there been an approved weight loss medicine that is so effective and yet also considered reasonably safe. ✔️ Wegovy is the newest glucagon-like peptide-1 receptor agonist (GLP-1RA). Glucagon-like peptide-1 (GLP-1) is an incretin, a metabolic [hormone](https://t.me/askmenow/3251) secreted from the L-cells of the small intestine and colon and specialized cells in the brainstem within a few minutes of eating. ✔️ In a two-year trial, Wegovy participants shed 15% body weight, dwarfing the control group's 3%. Trials also hinted at its potential benefits like reducing heart attack and stroke risks and aiding addiction treatment. ✔️ However, Wegovy's side effects, like nausea and a potential risk of thyroid cancers, caution against unbridled optimism. ℹ️ Global obesity affects 650 million adults, surpassing undernourished populations at 735 million. Subscribe- t.me/askmenow